Who Paid My Doc
ADVIA Centaur XP Analyzer
Device DX - Diagnostics incl. all products and services
PDI 00630414573564
General payments
$161,765
Research payments
$5,259,962
Through program year 2025, $161,765 in general payments and $5,259,962 in research payments were reported against ADVIA Centaur XP Analyzer (DX - Diagnostics incl. all products and services).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $430 | 1 |
| 2025 | Research | $232,513 | 16 |
| 2024 | General | $226 | 2 |
| 2024 | Research | $408,517 | 34 |
| 2023 | General | $20,009 | 9 |
| 2023 | Research | $260,617 | 14 |
| 2022 | General | $59,310 | 27 |
| 2022 | Research | $1,473,678 | 62 |
| 2021 | General | $81,790 | 24 |
| 2021 | Research | $2,884,637 | 230 |
Breakdown
Each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
63 general · 356 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.